Notably, we found that the FAP+ fibroblasts secreted CCN2, previously reported as a coactivator of the TGF-β pathway via direct binding to TGF-β [60], cooperating with TGF-β to activate the pathway, thus promoting the transition of tumor cells into the EMT-subtype. The gene discussed is TGFB1; the disease is neoplasm.